Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3564 studies found for:    Japan
Show Display Options
Rank Status Study
1 Completed
Has Results
Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Enoxaparin;   Drug: Rivaroxaban placebo;   Drug: Enoxaparin placebo
2 Completed 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension
Condition: Hypertension
Interventions: Drug: Telmisartan;   Drug: Hydrochlorothiazide;   Drug: Telmisartan + Hydrochlorothiazide
3 Active, not recruiting Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA)
Condition: Short Stature Born Small for Gestational Age (SGA)
Intervention: Drug: Genotropin (somatropin)
4 Completed Long-term Safety Study of Vildagliptin in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Drug: Vildagliptin
5 Completed
Has Results
An Extension Study of the Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Fingolimod
6 Active, not recruiting Febuxostat for Cerebral and caRdiorenovascular Events prEvEntion stuDy
Condition: Hyperuricemia
Intervention: Drug: Febuxostat
7 Terminated A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Neoplasms;   Carcinoma, Squamous Cell
Interventions: Drug: Surgery +(Cisplatin 80 mg/㎡+5FU 800mg/㎡×5days)×2;   Drug: (Cisplatin 80 mg/㎡+5FU 800mg/㎡×5days)×2+Surgery
8 Active, not recruiting Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)
Condition: Breast Cancer
Interventions: Drug: Placebo;   Drug: Denosumab
9 Completed
Has Results
Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism;   Thromboembolism;   Venous Thrombosis
Interventions: Drug: edoxaban tosylate(DU-176b);   Drug: low molecular weight heparin/unfractionated heparin;   Drug: warfarin
10 Active, not recruiting
Has Results
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Conditions: Hypertension, Pulmonary;   Ventricular Dysfunction, Left
Interventions: Drug: Riociguat (Adempas, BAY63-2521);   Drug: Placebo
11 Active, not recruiting UNITY 3: A Japanese Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 in Subjects With Genotype 1 Chronic Hepatitis C
Condition: Hepatitis C Virus Infection
Interventions: Drug: Daclatasvir;   Drug: Asunaprevir;   Drug: DCV 3DAA;   Other: Placebo for DCV 3DAA;   Other: Placebo for Daclatasvir;   Other: Placebo for Asunaprevir
12 Active, not recruiting ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dacomitinib (PF-00299804);   Drug: Active Comparator (erlotinib)
13 Recruiting Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients
Condition: Clear Cell Renal Carcinoma
Interventions: Drug: Axitinib;   Drug: Placebo
14 Completed
Has Results
Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs
Conditions: Stomach Ulcer;   Duodenal Ulcer
Interventions: Drug: Lansoprazole;   Drug: Gefarnate
15 Completed Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan
Condition: Chronic Myelogenous Leukemia
Intervention: Drug: Dasatinib
16 Completed Comparison Of Celecoxib 200 Mg Bid, Loxoprofen Sodium 60 Mg Tid And Placebo In Low Back Pain In Japan
Condition: Low Back Pain
Interventions: Drug: Celecoxib;   Drug: Placebo;   Drug: Loxoprofen
17 Recruiting Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects With Moderate to Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Adalimumab;   Other: Placebo
18 Completed Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Vildagliptin;   Drug: Placebo
19 Recruiting DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in Japan
Condition: Type 2 Diabetes Mellitus
20 Completed Double-Blind Study of Miglitol in Japanese With type2 Diabetes
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: miglitol

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years